Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Advanced Materials (Deerfield Beach, Fla.)|March 14, 2018
Air-Stable and High-Performance Solution-Processed Organic Light-Emitting Devices Based on Hydrophobic Polymeric Ionic Liquid Carrier-Injection LayersShugo Sato, Satoru Ohisa, Yukihiro Hayashi, et al.Journal of Gastroenterology|July 6, 2004
Risk factors for vitamin D deficiency in patients with Crohn's diseaseMasahiro Tajika, Akira Matsuura, Tsuneya Nakamura, et al.ACS Applied Materials & Interfaces|May 2, 2018
Conjugated Polyelectrolyte Blend with Polyethyleneimine Ethoxylated for Thickness-Insensitive Electron Injection Layers in Organic Light-Emitting DevicesSatoru Ohisa, Tetsuya Kato, Tatsuya Takahashi, et al.Bioorganic & Medicinal Chemistry Letters|April 29, 2009
Optimization of benzimidazole series as opioid receptor-like 1 (ORL1) antagonists: SAR study directed toward improvement of selectivity over hERG activityKensuke Kobayashi, Tetsuya Kato, Izumi Yamamoto, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2011
Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functionsNorihisa Mikami, Hiroaki Matsushita, Tetsuya Kato, et al.Gastrointestinal Endoscopy|April 24, 2003
A two-step method for marking polypectomy sites in the colon and rectumAkira Sawaki, Tsuneya Nakamura, Takashi Suzuki, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2007
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient miceKazutake Tsujikawa, Katsutoshi Yayama, Tamon Hayashi, et al.Journal of Medicinal Chemistry|June 23, 2009
Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S,4R)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]piperidine as clinical candidateAtsushi Satoh, Takeshi Sagara, Hiroki Sakoh, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2008
Identification of novel benzimidazole series of potent and selective ORL1 antagonistsOsamu Okamoto, Kensuke Kobayashi, Hiroshi Kawamoto, et al.Journal of Medicinal Chemistry|June 10, 2008
A novel class of cycloalkano[b]pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channelTakashi Yoshizumi, Hirobumi Takahashi, Hiroshi Miyazoe, et al.Pageof 3